Content about Belgium

March 14, 2014

Delhaize America, whose banners include Food Lion and Hannaford, posted an increase in fourth-quarter and full-year revenues as it completed the Food Lion phase roll out during the year.

BRUSSELS, Belgium — Delhaize America, whose banners include Food Lion and Hannaford, posted an increase in fourth-quarter and full-year revenues as it completed the Food Lion phase roll out during the year.

January 21, 2014

Actavis Pharma recently announced that it intends to enter into an agreement for Aurobindo Pharma to acquire Actavis' generics commercial operations in seven markets in Western Europe.

DUBLIN — Actavis Pharma recently announced that it intends to enter into an agreement for Aurobindo Pharma to acquire Actavis' generics commercial operations in seven markets in Western Europe. The transaction is conditional on certain antitrust approvals and completion of employee consultation processes. 

October 8, 2013

The CEO of Delhaize Group's European division has resigned, effective Oct. 31, the Belgian supermarket operator said.

BRUSSELS — The CEO of Delhaize Group's European division has resigned, effective Oct. 31, the Belgian supermarket operator said.

Delhaize said Stefan Descheemaeker had decided to resign as CEO of Delhaize Europe, though the company did not give a reason. Delhaize said that as a result of Descheemaeker's departure, Delhaize Group EVP and Delhaize Group Southeast Europe and Asia CEO Kostas Macheras would report directly to group CEO Pierre-Olivier Beckers, as would Delhaize Belgium CEO Dirk Van den Berghe, effective Nov. 1.

September 24, 2013

Belgian drug maker Ablynx is licensing an experimental treatment for rheumatoid arthritis and lupus to U.S. drug maker AbbVie in a deal worth up to $840 million.

GHENT, Belgium — Belgian drug maker Ablynx is licensing an experimental treatment for rheumatoid arthritis and lupus to U.S. drug maker AbbVie in a deal worth up to $840 million, the companies said.

The two drug makers announced that AbbVie would license the drug ALX-0061 for an upfront payment of $175 million plus milestone payments worth up to $665 million, as well as royalties. The drug belongs to a class known as anti-interleukin-6R nanobodies, which work by targeting an immune-system protein pathway that plays a key role in the inflammation associated with RA.

September 4, 2013

Belgian international food retailer Delhaize Group announced on Wednesday that both Roland Smith, CEO of Delhaize America, and Pierre-Olivier Beckers, CEO of Delhaize Group, are leaving the company.

BRUSSELS, Belgium — Belgian international food retailer Delhaize Group announced on Wednesday that both Roland Smith, CEO of Delhaize America, and Pierre-Olivier Beckers, CEO of Delhaize Group, are leaving the company.

June 26, 2013

Teva Pharmaceutical Industries and Mylan have launched generic versions of Pfizer's Viagra in nearly a dozen European countries, the two companies said.

NEW YORK — Teva Pharmaceutical Industries and Mylan have launched generic versions of Pfizer's Viagra in nearly a dozen European countries, the two companies said.

Teva, based in Jerusalem, announced the launch of generic sildenafil tablets in Germany, the United Kingdom, Italy, the Netherlands, Switzerland, Ireland, Austria, Belgium and Denmark. The company already markets generic versions of the erectile dysfunction drug in Spain and Canada.

May 23, 2013

Johnson & Johnson expects to file for Food and Drug Administration approval of more than 10 new drugs over the next four years, the drug maker said Thursday.

NEW BRUNSWICK, N.J. — Johnson & Johnson expects to file for Food and Drug Administration approval of more than 10 new drugs over the next four years, the drug maker said Thursday.

J&J's Janssen Pharmaceutical Cos. highlighted its more than 11 new product launches since 2009 and said it hoped to file with the FDA for more than two-dozen "significant" extensions to its branded drug lines by 2017.

May 8, 2013

Belgian international food retailer Delhaize Group, whose U.S. banners include Hannaford, Sweetbay and Food Lion, has announced that president and CEO Pierre-Olivier Beckers intends to retire from his executive role by the end of this year.

BRUSSELS, Belgium — Belgian international food retailer Delhaize Group, whose U.S. banners include Hannaford, Sweetbay and Food Lion, has announced that president and CEO Pierre-Olivier Beckers intends to retire from his executive role by the end of this year.
 
As part of Delhaize’s succession plan, Beckers will stay in his post until a new CEO is appointed and a smooth transition has taken place, the company stated. He will continue to serve on the board, in a nonexecutive capacity, after stepping down as CEO.

April 24, 2013

Johnson & Johnson subsidiary Janssen has launched an interactive educational website about diabetes for European healthcare professionals.

BEERSE, Belgium — Johnson & Johnson subsidiary Janssen has launched an interactive educational website about diabetes for European healthcare professionals.

Dubbed the Janssen Diabetes Forum, the website is designed to educate users about the latest developments in the management of Type 2 diabetes. The website was launched Tuesday in Beerse, Belgium.

August 30, 2012

Delhaize's U.S. division has a new leader.

BRUSSELS — Delhaize's U.S. division has a new leader.

The supermarket conglomerate announced that Roland Smith will serve as Delhaize America's president and CEO, as well as EVP of the Delhaize Group, effective Oct. 15. Smith is replacing Ronald Hodge, who will be retiring from his post this year. Hodge will serve in an advisory role to ensure a smooth transition.

August 29, 2012

In the battle to find a cure for amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease, scientists from Belgium have made a rare discovery: a new gene that influences survival time of ALS. The findings, reported in a recent issue of Nature Medicine, were funded in part by CVS/pharmacy and the ALS Therapy Alliance, a Boston-based nonprofit.

NEEDHAM, Mass. — In the battle to find a cure for amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease, scientists from Belgium have made a rare discovery: a new gene that influences survival time of ALS. The findings, reported in a recent issue of Nature Medicine, were funded in part by CVS/pharmacy and the ALS Therapy Alliance, a Boston-based nonprofit. The findings also confirm another recent study that identified the same pathway to finding a treatment for ALS.

December 15, 2010

Johnson & Johnson on Wednesday announced that Alex Gorsky, currently worldwide chairman of medical devices and diagnostics, and Sheri McCoy, currently worldwide chairman of pharmaceuticals, have been appointed vice chairmen of the executive committee, joining William Weldon, J&J chairman and CEO, in an expanded Office of the Chairman.

NEW BRUNSWICK, N.J. — Johnson & Johnson on Wednesday announced that Alex Gorsky, currently worldwide chairman of medical devices and diagnostics, and Sheri McCoy, currently worldwide chairman of pharmaceuticals, have been appointed vice chairmen of the executive committee, joining William Weldon, J&J chairman and CEO, in an expanded Office of the Chairman.

Both appointments are effective Jan. 3.

September 30, 2010

Shareholders of Belgian drug maker Movetis have put up nearly all of their shares for...

DUBLIN Shareholders of Belgian drug maker Movetis have put up nearly all of their shares for sale as British drug maker Shire moves to acquire the company, Shire said Thursday.

 

Shire said 99.18% of Movetis’ shares had been tendered as of Monday.

 

 

Shire announced last month that it would buy Movetis for $567 million. The Turnhout, Belgium-based company makes gastroenterology drugs.

 

August 8, 2010

British drug maker Shire will acquire Belgian drug maker Movetis for $567 million, Movetis said....

February 13, 2008

Remedent, a Belgium-based company specializing in oral care and cosmetic dentistry products, has received an...

September 11, 2007

L’Oreal is taking legal action against eBay in five European countries, alleging that the online...